Evidence map›Paper›PMID 32355510›Full record

ReviewJournal de chirurgie viscerale2020

[Endocrine surgery during and after the COVID-19 epidemic: Guidelines from AFCE].

G Baud, L Brunaud, J C Lifante, C Tresallet, F Sebag, J P Bizard, M Mathonnet, F Menegaux, R Caiazzo, É Mirallié and 2 more

Abstract readEnglish AbstractReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal de chirurgie viscerale, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

G BaudChirurgie générale et endocrinienne, CHU de Lille, 59000 Lille, France.
L BrunaudChirurgie viscérale, métabolique et cancérologique (CVMC), CHRU de Nancy, 54511 Vandœuvre-lès-Nancy, France.
J C LifanteChirurgie digestive, oncologique et endocrinienne, CHU de Lyon, 69310 Pierre-Bénite, France.
C TresalletChirurgie digestive, bariatrique et endocrinienne, AP-HP, Hôpital Avicenne, université Sorbonne Paris Nord, 93000 Bobigny, France.
F SebagChirurgie générale et endocrinienne, AP-HM, La Conception, 13005 Marseille, France.
J P BizardChirurgie endocrinienne et viscérale, hôpital privé Arras-lès-Bonnettes, 62000 Arras, France.
M MathonnetChirurgie digestive et endocrinienne, CHU de Limoges, 87000 Limoges, France.
F MenegauxChirurgie générale digestive et endocrinienne, Sorbonne université, hôpital Pitié-Salpêtrière, AP-HP, 75013 Paris, France.
R CaiazzoChirurgie générale et endocrinienne, CHU de Lille, 59000 Lille, France.
É MiralliéChirurgie cancérologique, digestive et endocrinienne (CCDE), CHU de Nantes, 44093 Nantes, France.
F PattouChirurgie générale et endocrinienne, CHU de Lille, 59000 Lille, France.
Groupe d'étude AFCE COVID AFCE COVID Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic commands a major reorganization of the entire French healthcare system. In France, general rules have been issued nationally and implemented by each healthcare center, both public and private, throughout France. Guidelines drafted by an expert group led by the French-speaking Association of Endocrine Surgery (AFCE) propose specific surgical management principles for thyroid, parathyroid, endocrine pancreas and adrenal surgery during and after the COVID-19 epidemic.

Indexed as

AdrenalCoronavirusCOVID-19Endocrine surgeryNeuroendocrine tumorParathyroidThyroid

Identifiers

PMID32355510
PMCPMC7190492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.